人才建设

您所在的位置: 首页 - 人才建设 - 师资队伍 - 准聘长聘教师 - 助理教授 - 放射医学研究所

放射医学研究所

个人简介

刘强,1974年出生,籍贯河北,永利集团3044官网欢迎您放射医学研究所研究员,二级教授,博士生导师。1993年考入天津医科大学临床医学专业,获得学士学位。2008年在永利集团3044官网欢迎您攻读博士学位,从事放射医学研究。1998年进入永利集团3044官网欢迎您放射医学研究所工作,2011年升为研究员。现任永利集团3044官网欢迎您放射医学系副主任,永利集团3044官网欢迎您放射医学研究所辐射损伤效应研究室主任、放射卫生研究室主任。


主要研究方向

主要从事肿瘤放疗基础研究,辐射损伤的救治技术研究,辐射诱导的DNA损伤修复机制研究,低剂量辐射暴露人员队列的健康效应研究。


代表性成果

1. Gu Y#, Meng G, Zhang Q, Liu L, Wu H, Zhang S, Wang Y, Zhang T, Wang X, Sun S, Wang X, Jia Q, Song K, Liu Q*, Niu K*. Association of longitudinal trends in thyroid function with incident carotid atherosclerosis in middle-aged and older euthyroid subjects: the Tianjin Chronic Low-Grade Systemic Inflammation and Health (TCLSIH) cohort study. Age and Ageing. 2022, 51:1-10. (IF=12.782)

2. Song H#, Su Q, Shi W, Huang P*, Zhang C, Zhang C, Liu Q*, Wang W*. Antigen epitope-TLR7/8a conjugate as self-assembled carrier-free nanovaccine for personalized immunotherapy. Acta Biomaterialia. 2022, 141:398-407. (IF=10.633)

3. Li H#, Liang X#, Duan J, Chen Y, Tian X, Wang J, Zhang H, Liu Q*, Yang J*. ROS-responsive EPO nanoparticle ameliorates ionizing radiation-induced hematopoietic injury. Biomater Sci. 2021,9(19), 6474-6485. (IF=7.59)

4. Cao JL#, Tu WJ#*, Cheng W, Yu L, Liu YK, Hu X*, Liu Q*. Clinical features and short-term outcomes of 102 patients with coronavirus disease 2019 in Wuhan, China. Clin Infect Dis. 2020, 71(15):748-755. (IF=9.055, C100, ESI)

5. Sun X#, Wang Y, Ji K, Liu Y, Kong Y, Nie S, Li N, Hao J, Xie Y, Xu C*, Du L*, Liu Q*. NRF2 preserves genomic integrity by facilitating ATR activation and G2 cell cycle arrest. Nucleic Acids Res. 2020, 48(16):9109-9123. (IF=16.971)

6. Tu WJ#, Cao JL, Yu L, Hu XR*, Liu Q*. Clinicolaboratory study of 25 fatal cases of COVID-19 in Wuhan. Intensive Care Med. 2020, 46(6):1117-1120. (IF=18.967)

7. Cao JL#, Hu XR#,Cheng WL, Yu L, Tu WJ*, Liu Q*. Clinical features and short-term outcomes of 18 patients with corona virus disease 2019 in intensive care unit. Intensive Care Med. 2020, 46(5):851-853. (IF=18.967)

8. Du Y#, Sun H#, Lux F, Xie Y, Du L, Xu C, Zhang H, He N, Wang J, Liu Y, Leduc G, Doussineau T, Ji K, Wang Q, Lin Z, Wang Y*, Liu Q*, Tillement O. Radiosensitization effect of AGuIX, a gadolinium-based nanoparticle, in nonsmall cell lung cancer. ACS Appl Mater Interfaces. 2020 Dec 23;12(51):56874-56885. (IF=9.229)

9. Tu WJ#, Wang Hong#, Si Song, Liu Q*, Sha H*. The anti-inflammatory and anti-oxidant mechanisms of the Keap1/Nrf2/ARE signaling pathway in chronic diseases. Aging Dis. 2019,10(3):637-651. (IF=5.402, C100)

10. Tu WJ#, Qiu HC#, Zhang Y, Cao JL, Wang H, Zhao JZ*, Liu Q*, Zeng X*. Lower serum retinoic acid level for prediction of higher risk of mortality in ischemic stroke. Neurology. 2019 Apr 9;92(15):e1678-e1687. (IF=8.77)